Christopher J Babbitt Selected Research

Christopher J Babbitt Research Topics

6	COVID-19 03/2024 - 01/2021
3	Critical Illness (Critically Ill) 03/2023 - 01/2018
2	Fever (Fevers) 01/2021 - 01/2021
2	COVID-19 related pediatric multisystem inflammatory disease 01/2021 - 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Neoplasms (Cancer) 03/2024
1	Coinfection 03/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Human Influenza (Influenza) 01/2023
1	Central Nervous System Infections (Central Nervous System Infection) 01/2023
1	Respiratory Syncytial Virus Infections 01/2023
1	Disease Progression 05/2022
1	Myocarditis (Carditis) 02/2022
1	Inflammation (Inflammations) 01/2021
1	Shock 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Dyskinesias (Dyskinesia) 09/2013
1	Seizures (Absence Seizure) 09/2013
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 09/2013
1	Hypoventilation 09/2013
1	Accidental Injuries 03/2013
1	Cardiomyopathies (Cardiomyopathy) 03/2002
1	Heart Failure 03/2002
1	Fibrosis (Cirrhosis) 03/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2002

3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2002
2	Glucose (Dextrose)FDA LinkGeneric 03/2013 - 03/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2023
1	VaccinesIBA 01/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	AT 61IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Dexmedetomidine FDA Link 09/2013
1	Integrin beta1IBA 03/2002
1	IntegrinsIBA 03/2002

6	Critical Care (Surgical Intensive Care) 03/2024 - 09/2013
3	Therapeutics 05/2022 - 09/2013
2	Length of Stay 01/2023 - 01/2018
1	Organ Transplantation 03/2024
1	Enteral Nutrition (Feeding, Tube) 01/2018